ENAapplication/xmlftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR744/007/ERR7441047/ERR7441047.fastq.gzprimaryOK200GenomicsRobert Koch Instituthttps://www.ebi.ac.uk/ena/browser/view/PRJEB49077We work with Klebsiella (pneumoniae) as a major hospital and ambulatory pathogen. Focus is on MDR and XDR isolates in the context of human infections, but also on pathogenic variants like hypervirulent and hypermucoviscous variants. We investigate a potential one health dimension of Klebsiella as a human and animal pathogen. In addition and in this regard, we analyze host-pathogen interactions with various Klebsiella variants and (host/mammalian) cell linesENADmelCG6525, PSENL3, IMP1, T18E12_21, MSTP086, signal peptide peptidase, H13, signal peptide peptidase activity., PSL3, SPPL1, CG6525, IMPAS-1, dJ324O17.1, T18E12.21, Spp, spp, SPP, IMPAS, FBgn0082831, ATSPP, Donovania, Calymmatobacterium, HyalococcusDmelCG6525, PSENL3, IMP1, T18E12_21, MSTP086, signal peptide peptidase, H13, signal peptide peptidase activity., PSL3, SPPL1, CG6525, IMPAS-1, dJ324O17.1, T18E12.21, Spp, spp, SPP, IMPAS, FBgn0082831, ATSPP, Donovania, Calymmatobacterium, HyalococcusfalseThe various facets of Klebsiella spp. as a pathogenThe various facets of Klebsiella spp. as a pathogen2021-11-292021-11-29PRJEB49077